Juliet Tammenoms Bakker, Ten Percent Owner at Corcept Therapeutics, holds 31.39K shares in RxSight (Ticker: RXST), holds 10.02K shares in Eargo (Ticker: EAR), holds 1.96M shares in Axonics Modulation Technologies (Ticker: AXNX). Most recently, Juliet Tammenoms Bakker Bought ― shares of RxSight on Feb 15, 2024 for an estimated value of 406.60K.